FDA Drug Recalls

Recalls / Class II

Class IID-0210-2021

Product

PHENYLephrine HCl 500 mcg/5mL in 0.9% Sodium Chloride (100 mcg/mL), Rx Only, 5 mL Single Dose Syringe, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004081011

Affected lot / code info
Lot # 1220022958, BUD 1/20/2021; 1220023013, BUD 1/18/2021; 1220023035, BUD 1/19/2021; 1220023036, BUD 1/21/2021; 1220023059, BUD 1/21/2021; 1220023094, BUD 1/25/2021; 1220023167, BUD 1/26/2021; 1220023208, BUD 1/27/2021; 1220023291, BUD 1/31/2021; 1220023359, BUD 2/2/2021; 1220023401, BUD 2/2/2021 & 1220023473, BUD 2/4/2021.

Why it was recalled

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

Recalling firm

Firm
SCA Pharmaceuticals
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
755 Rainbow Rd Ste B, Windsor, Connecticut 06095-1024

Distribution

Quantity
14,580 syringes
Distribution pattern
Product was distributed to hospitals nationwide.

Timeline

Recall initiated
2020-12-17
FDA classified
2021-01-07
Posted by FDA
2021-01-13
Terminated
2021-11-02
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0210-2021. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.